Aluna Vein Centers: Ramtin Massoudi, MD is categorized under Business Services (Unclassified) in Beverly Hills, CA .
Aluna Vein Centers: Ramtin Massoudi, MD was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Business Services (Unclassified) business, which does work in the B2B market, and is classified as a Business Services (Unclassified), under code number by the NAICS.
If you are seeking more information, feel free to contact at the company’s single location by writing to 8500 Wilshire Blvd #518, Beverly Hills, California CA 90211 or by phoning (310) 855-7171. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Aluna Vein Centers: Ramtin Massoudi, MD |
| Address: | 8500 Wilshire Blvd #518, Beverly Hills, California 90211 |
| Phone Number: | (310) 855-7171 |
| Website Address: | alunaveincenters.com |
| Annual Revenue (USD): | Unknown |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Services (Unclassified) |
| Share This Business: |
Aluna Vein Centers: Ramtin Massoudi, MD was started in 0 to provide professional Business Services (Unclassified) under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact for inquiries that concern Aluna Vein Centers: Ramtin Massoudi, MD by calling the company number (310) 855-7171, as your correspondence is most welcome. Additionally, the physical location of the single location of Aluna Vein Centers: Ramtin Massoudi, MD can be found at the coordinates 34.0649689,-118.3766787 as well as the street address 8500 Wilshire Blvd #518 in Beverly Hills, California 90211.
For its online presence, you may visit Aluna Vein Centers: Ramtin Massoudi, MD’s website at alunaveincenters.com and engage with its social media outlets through on Twitter and on Facebook.